NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/05/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization234.13 mln
Float33.55 mln
Earnings Date08/18/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
5.72
Highly suspicious
1-Year Forecast
12.17
Transformational upside
Relative Strength
24
/ 100
Significantly lagging
Debt / Equity
0.38
Low leverage
ROE
-176
Deeply negative
Business Description
Orchestra BioMed Holdings Inc. is a US-based medical technology company focused on developing innovative devices and therapies to treat serious cardiovascular and other chronic conditions, including high blood pressure, heart failure, and arterial disease. Its key programs use bioelectronic and device-based approaches to address conditions that are difficult to manage with conventional treatments. The company works alongside major industry partners, including Medtronic and Terumo, to bring these technologies to market. Founded in 2018 and based in New Hope, Pennsylvania, Orchestra BioMed also offers surgical support tools and devices designed to improve the safety and effectiveness of minimally invasive procedures.
